General Neurology

Abstract

In this chapter, we finish presenting the P&S data we have to date on the remainder of the fields within neurology, including Parkinson’s disease, multiple system atrophy, pure autonomic failure, multiple sclerosis, epilepsy, unexplained seizures, abnormal sweating, and Sörgren’s disease. P&S monitoring, in large part, had its start in cardiology and was significantly promoted in endocrinology (specifically diabetology). However, it is hoped that in bringing more information to light regarding a largely, heretofore, unmeasured portion of the nervous system, neurology will accelerate its growth. The purpose of P&S monitoring is to augment the field of autonomic nervous system monitoring, not to replace anything. P&S monitoring has its role. It is an easy to implement, apply, and utilize tool to assess, treat, and maintain patients who are known to be at risk for autonomic neuropathy before autonomic neuropathy is demonstrated. There is a point beyond which P&S monitoring is no longer effective, because at the level of the heart, there is not enough autonomic function remaining to be measured. It is at this point that traditional autonomic tests, including tilt table, become more effective. Several of the patient types that typically push the limits of P&S monitoring are presented in this section and include patients with advanced Parkinson’s, advanced multiple system atrophy, pure autonomic failure, and severe tremors and movement disorders.